Vaxart, Inc. Appoints Samir Singh As Senior Vice President, Corporate Development And Strategy

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, Inc., a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today the appointment of Samir Singh as senior vice president, corporate development and strategy.

Back to news